Home
Live Updates
SGLT2 Inhibitors Reduce Kidney Stone Risk in Type 2 Diabetes : comparemela.com
SGLT2 Inhibitors Reduce Kidney Stone Risk in Type 2 Diabetes
Patients with type 2 diabetes treated with SGLT2 inhibitors vs other common diabetes drugs show up to a 31% reduced risk of kidney stone development.
Related Keywords
Massachusetts ,
United States ,
Boston ,
Julie Paik ,
Division Of Pharmacoepidemiology ,
Division Of Renal Kidney Medicine At Brigham ,
Medscape Medical ,
Urinary Citrate ,
Diabetes Mellitus Type 2 ,
Iabetes Mellitus Type Ii ,
Type 2 Diabetes ,
Ype 2 Dm ,
T2dm ,
2d ,
Kidney Stones ,
Nephrolithiasis ,
Renal Calculus ,
Renal Calculi ,
Kidneys ,
Sglt2 Inhibitors ,
Odium Glucose Transporter 2 Inhibitors ,
Odium Glucose Co Transporter 2 Inhibitors ,
Sodium Glucose Cotransporter 2 Inhibitors ,
Renal Disease ,
Kidney Disease ,
Kidney Disorder ,
Renal Disorder ,
Ephropathy ,
Renal Failure ,
comparemela.com © 2020. All Rights Reserved.